Baseline characteristics
| Sample size (n) | 247 |
| Mean age, years (SD) | 61 (15) |
| Males, n (%) | 84 (34) |
| Mean tumour max size, mm (SD) | 26 (15) |
| Stage, n (%) | |
| IA | 129 (56) |
| IB | 50 (22) |
| IIA | 24 (10) |
| IIB | 11 (5) |
| IIIA | 16 (7) |
| IIIB or IV | 0 |
| Histology, n (%) | |
| Typical carcinoid | 217 (88) |
| Atypical carcinoid | 30 (12) |
| Mean FDG PET-CT SUV max (SD) | |
| Typical carcinoid | 4.6 (3.8) |
| Atypical carcinoid | 6.1 (4.4) |
| Surgical procedure, n (%) | |
| No resection | 2 (1) |
| Wedge resection | 19 (8) |
| Segmentectomy | 5 (2) |
| Lobectomy | 208 (84) |
| Pneumonectomy | 13 (5) |
| Contingency table results, n | |
| PET-CT positive/pathology positive | 2 |
| PET-CT positive/pathology negative | 13 |
| PET-CT negative/pathology positive | 4 |
| PET-CT negative/pathology negative | 188 |
FDG PET-CT, 18Fluoro-dexoy-glucose positron emission tomography-CT.